Copyright Reports & Markets. All rights reserved.

Global Allogeneic Stem Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Allogeneic Stem Cells by Type
    • 1.3.1 Overview: Global Allogeneic Stem Cells Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Allogeneic Stem Cells Consumption Value Market Share by Type in 2023
    • 1.3.3 Progesterone Oral
    • 1.3.4 Progesterone Injection
    • 1.3.5 Progesterone Suspended/Gel
  • 1.4 Global Allogeneic Stem Cells Market by Application
    • 1.4.1 Overview: Global Allogeneic Stem Cells Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Pharmacies & Drug Stores
  • 1.5 Global Allogeneic Stem Cells Market Size & Forecast
  • 1.6 Global Allogeneic Stem Cells Market Size and Forecast by Region
    • 1.6.1 Global Allogeneic Stem Cells Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Allogeneic Stem Cells Market Size by Region, (2019-2030)
    • 1.6.3 North America Allogeneic Stem Cells Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Allogeneic Stem Cells Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Allogeneic Stem Cells Market Size and Prospect (2019-2030)
    • 1.6.6 South America Allogeneic Stem Cells Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Allogeneic Stem Cells Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Allogeneic Stem Cells Product and Solutions
    • 2.1.4 Merck Allogeneic Stem Cells Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Merck Recent Developments and Future Plans
  • 2.2 Teva Generics
    • 2.2.1 Teva Generics Details
    • 2.2.2 Teva Generics Major Business
    • 2.2.3 Teva Generics Allogeneic Stem Cells Product and Solutions
    • 2.2.4 Teva Generics Allogeneic Stem Cells Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Teva Generics Recent Developments and Future Plans
  • 2.3 Zhejiang Medicine
    • 2.3.1 Zhejiang Medicine Details
    • 2.3.2 Zhejiang Medicine Major Business
    • 2.3.3 Zhejiang Medicine Allogeneic Stem Cells Product and Solutions
    • 2.3.4 Zhejiang Medicine Allogeneic Stem Cells Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Zhejiang Medicine Recent Developments and Future Plans
  • 2.4 Zhejiang Aisheng Pharmaceutical
    • 2.4.1 Zhejiang Aisheng Pharmaceutical Details
    • 2.4.2 Zhejiang Aisheng Pharmaceutical Major Business
    • 2.4.3 Zhejiang Aisheng Pharmaceutical Allogeneic Stem Cells Product and Solutions
    • 2.4.4 Zhejiang Aisheng Pharmaceutical Allogeneic Stem Cells Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Zhejiang Aisheng Pharmaceutical Recent Developments and Future Plans
  • 2.5 Besins Healthcare
    • 2.5.1 Besins Healthcare Details
    • 2.5.2 Besins Healthcare Major Business
    • 2.5.3 Besins Healthcare Allogeneic Stem Cells Product and Solutions
    • 2.5.4 Besins Healthcare Allogeneic Stem Cells Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Besins Healthcare Recent Developments and Future Plans
  • 2.6 Virtus Pharmaceuticals
    • 2.6.1 Virtus Pharmaceuticals Details
    • 2.6.2 Virtus Pharmaceuticals Major Business
    • 2.6.3 Virtus Pharmaceuticals Allogeneic Stem Cells Product and Solutions
    • 2.6.4 Virtus Pharmaceuticals Allogeneic Stem Cells Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Virtus Pharmaceuticals Recent Developments and Future Plans
  • 2.7 BionPharma
    • 2.7.1 BionPharma Details
    • 2.7.2 BionPharma Major Business
    • 2.7.3 BionPharma Allogeneic Stem Cells Product and Solutions
    • 2.7.4 BionPharma Allogeneic Stem Cells Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 BionPharma Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Allogeneic Stem Cells Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Allogeneic Stem Cells by Company Revenue
    • 3.2.2 Top 3 Allogeneic Stem Cells Players Market Share in 2023
    • 3.2.3 Top 6 Allogeneic Stem Cells Players Market Share in 2023
  • 3.3 Allogeneic Stem Cells Market: Overall Company Footprint Analysis
    • 3.3.1 Allogeneic Stem Cells Market: Region Footprint
    • 3.3.2 Allogeneic Stem Cells Market: Company Product Type Footprint
    • 3.3.3 Allogeneic Stem Cells Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Allogeneic Stem Cells Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Allogeneic Stem Cells Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Allogeneic Stem Cells Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Allogeneic Stem Cells Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Allogeneic Stem Cells Consumption Value by Type (2019-2030)
  • 6.2 North America Allogeneic Stem Cells Market Size by Application (2019-2030)
  • 6.3 North America Allogeneic Stem Cells Market Size by Country
    • 6.3.1 North America Allogeneic Stem Cells Consumption Value by Country (2019-2030)
    • 6.3.2 United States Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Allogeneic Stem Cells Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Allogeneic Stem Cells Consumption Value by Type (2019-2030)
  • 7.2 Europe Allogeneic Stem Cells Consumption Value by Application (2019-2030)
  • 7.3 Europe Allogeneic Stem Cells Market Size by Country
    • 7.3.1 Europe Allogeneic Stem Cells Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 7.3.3 France Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Allogeneic Stem Cells Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Allogeneic Stem Cells Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Allogeneic Stem Cells Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Allogeneic Stem Cells Market Size by Region
    • 8.3.1 Asia-Pacific Allogeneic Stem Cells Consumption Value by Region (2019-2030)
    • 8.3.2 China Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 8.3.5 India Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Allogeneic Stem Cells Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Allogeneic Stem Cells Consumption Value by Type (2019-2030)
  • 9.2 South America Allogeneic Stem Cells Consumption Value by Application (2019-2030)
  • 9.3 South America Allogeneic Stem Cells Market Size by Country
    • 9.3.1 South America Allogeneic Stem Cells Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Allogeneic Stem Cells Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Allogeneic Stem Cells Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Allogeneic Stem Cells Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Allogeneic Stem Cells Market Size by Country
    • 10.3.1 Middle East & Africa Allogeneic Stem Cells Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Allogeneic Stem Cells Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Allogeneic Stem Cells Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Allogeneic Stem Cells Market Drivers
  • 11.2 Allogeneic Stem Cells Market Restraints
  • 11.3 Allogeneic Stem Cells Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Allogeneic Stem Cells Industry Chain
  • 12.2 Allogeneic Stem Cells Upstream Analysis
  • 12.3 Allogeneic Stem Cells Midstream Analysis
  • 12.4 Allogeneic Stem Cells Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Progesterone is a steroid hormone involved in the female menstrual cycle, pregnancy, and the embryonic development of humans and other species. Progesterone belongs to a class of hormones called progestogens. This steroid hormone is produced in the ovaries, the adrenal glands, and in the placenta during pregnancy.
    According to our (Global Info Research) latest study, the global Allogeneic Stem Cells market size was valued at US$ 867 million in 2023 and is forecast to a readjusted size of USD 1694 million by 2030 with a CAGR of 10.2% during review period.
    In the past, in the field of upstream production of steroid drugs, due to the late start of domestic biotechnology research, it was relatively backward compared to foreign manufacturers. However, after decades of development, China"s production technology has been continuously improved, and its cost advantage is more obvious. Now, domestic steroid raw material manufacturers have gradually become the mainstream suppliers of steroid drug products, and foreign steroid drug giants have used steroid drugs upstream. Procurement of product starting materials and intermediates shifted to Asia-Pacific region, mainly China, and global steroid drug production center gradually moved to Asia-Pacific region.
    The Progesterone is a high concentration industry. The annual production is about few hundred Tonnes. Currently, the global top three manufacturers are: Merck, Teva Generics, Zhejiang Xianju Pharmaceutical. Their revenue market share is about 52%. In short future, the competition pattern will not change.
    This report is a detailed and comprehensive analysis for global Allogeneic Stem Cells market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Allogeneic Stem Cells market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Allogeneic Stem Cells market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Allogeneic Stem Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Allogeneic Stem Cells market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Allogeneic Stem Cells
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Allogeneic Stem Cells market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Teva Generics, Zhejiang Medicine, Zhejiang Aisheng Pharmaceutical, Besins Healthcare, Virtus Pharmaceuticals, BionPharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Allogeneic Stem Cells market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Allogeneic Stem Cells market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Progesterone Oral
    Progesterone Injection
    Progesterone Suspended/Gel
    Market segment by Application
    Hospital
    Clinic
    Pharmacies & Drug Stores
    Market segment by players, this report covers
    Merck
    Teva Generics
    Zhejiang Medicine
    Zhejiang Aisheng Pharmaceutical
    Besins Healthcare
    Virtus Pharmaceuticals
    BionPharma
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Allogeneic Stem Cells product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Allogeneic Stem Cells, with revenue, gross margin, and global market share of Allogeneic Stem Cells from 2019 to 2024.
    Chapter 3, the Allogeneic Stem Cells competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Allogeneic Stem Cells market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Allogeneic Stem Cells.
    Chapter 13, to describe Allogeneic Stem Cells research findings and conclusion.

    Buy now